ESC 365 - A longitudinal evaluation of cardiovascular risk factors, treatment patterns, and outcomes in patients with documented cardiovascular disease treated with lipid lowering therapy in the United Kingdom

ESC Premium Access

A longitudinal evaluation of cardiovascular risk factors, treatment patterns, and outcomes in patients with documented cardiovascular disease treated with lipid lowering therapy in the United Kingdom

Session: Cardiovascular Disease Prevention and Treatment: What Drives Change?

Topic: Public Health

Speaker: Doctor E. Sidelnkov (Rotkreuz, CH)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Eduard Sidelnkov

Amgen (Europe) GmbH, Rotkreuz (Switzerland)

0 follower

4 more presentations in this session

Determinants of statin initiation and discontinuation in the secondary prevention of atherosclerotic cardiovascular disease in Scotland during 2009-2017

Speaker: Ms I. Thalmann (Oxford, GB)

Management of conflicts of interests of ESC guideline authors

Speaker: Professor H. Seggewiss (Wurzburg, DE)

Burnout in residency: are cardiology residents more affected?

Speaker: Mr A. Sigal (Buenos Aires, AR)

The assessment of the accuracy and credibility of cardiovascular health information on social media platforms

Speaker: Doctor A. Ragab (Rotterdam, NL)

Access the full session

Cardiovascular Disease Prevention and Treatment: What Drives Change?

Speakers: Doctor E. Sidelnkov, Ms I. Thalmann, Professor H. Seggewiss, Mr A. Sigal, Doctor A. Ragab

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources